Carmat SA (CKMTF)

12.75 0.00 (0.00%) At close: 12:11PM EDT

Carmat SA

36, avenue de l'Europe
Immeuble l'Etendard
Vélizy-Villacoublay 78140
France
33 1 39 45 64 50
https://www.carmatsa.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 177

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Stephane Piat	CEO & Director	832.56k	N/A	1971
Ms. Pascale d'Arbonneau	CFO & Head of investor relations	N/A	N/A	N/A
Ms. Raouia Bouyanzer	Human Resources Director	N/A	N/A	N/A
Dr. Petrus Jansen	Chief Medical Officer	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. Its product includes Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.

Corporate governance

Carmat SA’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.